Neural Regeneration Research ›› 2026, Vol. 21 ›› Issue (10): 4906-4907.doi: 10.4103/NRR.NRR-D-25-01311
Previous Articles Next Articles
Genta Ito*, Naoko Utsunomiya-Tate
Online:
Published:
Contact:
Supported by:
Abstract: Non-enzymatic isomerization of aspartic acid residues in proteins associated with Alzheimer’s disease: Proteins are composed of L-amino acids following ribosomal translation. However, if they remain unmetabolized for an extended period, some residues (particularly aspartic acid [Asp]) undergo isomerization to the D-form. This process begins with nucleophilic attack (by the nitrogen atom of the amide group of an adjacent residue) on the side-chain carboxy group of an Asp residue. This forms a fivemembered L-succinimide intermediate, which has two carbonyl carbons and can transform back to an L-Asp residue or isomerize into an L-isoAsp residue. The chiral center of the L-succinimide intermediate can easily invert to form a D-succinimide intermediate via keto-enol tautomerization. This D-succinimide intermediate then cleaves to yield a D-aspartic acid (D-Asp) or D-isoaspartate (D-isoAsp) residue.
Genta Ito, Naoko Utsunomiya-Tate. Potential roles of aspartic acid D-isomerization in proteins implicated in the pathogenesis of Alzheimer's disease[J]. Neural Regeneration Research, 2026, 21(10): 4906-4907.
/ / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.sjzsyj.com.cn/EN/10.4103/NRR.NRR-D-25-01311
https://www.sjzsyj.com.cn/EN/Y2026/V21/I10/4906